Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Hypnosis shows promise for Parkinson's pain relief

NCT ID NCT04259203

Symptom relief Sponsor: University Hospital, Lille Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether Erickson hypnosis can reduce chronic pain in people with Parkinson's disease. 33 participants were split into two groups: one received weekly hypnosis sessions for 2 months, the other got usual care. The main goal was to see if pain intensity changed from start to end of the study.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Erickson hypnosis sessions
What this could lead to
If it works, this could offer a non-drug way to ease chronic pain for people with Parkinson's disease.
What could go wrong
This is a very small, early study with only 33 participants. The results may not apply to everyone, and the effect might be small or temporary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

33 people

The number who actually took part.

Started

Aug 2020

Finished

Aug 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Men or women * 18 to 80 years old * idiopathic Parkinson's disease * without neurological co-morbidity * Suffering from chronic pain (for at least 3 months), related to Parkinson's disease * Having a pain intensity of at least 30 mm on the VAS (average intensity over the previous week) for Parkinson's disease-related pain * antiparkinsonian, analgesic and psychotropic treatments stable for 1-month * having a health insurance * signed informed consent form Exclusion Criteria: * Patient with a neurological condition other than Parkinson's disease or with an atypical Parkinson's syndrome * Early untreated patient * Patient with acute intercurrent pain * Patient whose pain is mainly attributable to another pathology (rheumatoid arthritis, spondyloarthritis ankylosing, diabetic neuropathy, cancer, etc.) * Patient with cognitive impairment objectified by a score at the Montreal Cognitive Assessment (MoCA) \<24 * Patient with hallucinations and/or psychosis (MDS-UPDRS 1.2\> 1) * Patient with a apathy (MDS-UPDRS 1.5\> 1) * Patient with disabling dyskinesia (MDS-UPDRS) 4.1 AND 4.2\> 1) * Patient under the protection of adults * Pregnant or lactating woman

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic pain Parkinson disease

Contacts and locations

Locations

  • Chu Cote de Nacre

    Caen, France

  • Hopital Charles Nicolle Chu Rouen

    Rouen, France

  • Hopital Purpan Chu Toulouse

    Toulouse, 31300, France

  • Hôpital Roger Salengro, CHRU de Lille

    Lille, 59800, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.